| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.62 | 0.03 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.43 | 0.005 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.41 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |